ZYDUSLIFE Zydus Lifesciences Ltd Product Launches Announcement 2025 - Launch of ANVIMO Zydus Lifesciences launched ANVIMO, an affordable breakthrough treatment for Cytomegalovirus (CMV) infection in transplant patients on March 5, 2025, significantly reducing costs by 91%. ANVIMO ensures better safety and effectiveness compared to existing treatments, improving access to life-saving care for Indian patients..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd